Cargando…
COVID-19 and pediatric fatty liver disease: Is there interplay?
The rapid global spread of coronavirus disease 2019 (COVID-19) infection has become a major health issue with higher morbidity and mortality rates. Besides respiratory symptoms, a growing body of evidence indicates a variety of gastrointestinal manifestations including liver involvement. In this reg...
Autores principales: | Di Sessa, Anna, Lanzaro, Francesca, Zarrilli, Sarah, Picone, Vittorio, Guarino, Stefano, Miraglia del Giudice, Emanuele, Marzuillo, Pierluigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192281/ https://www.ncbi.nlm.nih.gov/pubmed/34168408 http://dx.doi.org/10.3748/wjg.v27.i22.3064 |
Ejemplares similares
-
Metabolic-associated fatty liver disease from childhood to adulthood: State of art and future directions
por: Lanzaro, Francesca, et al.
Publicado: (2022) -
Advances in paediatric nonalcoholic fatty liver disease: Role of lipidomics
por: Di Sessa, Anna, et al.
Publicado: (2021) -
Pediatric non-alcoholic fatty liver disease: current perspectives on diagnosis and management
por: Di Sessa, Anna, et al.
Publicado: (2019) -
Omics era in type 2 diabetes: From childhood to adulthood
por: Passaro, Antonio Paride, et al.
Publicado: (2021) -
Telemedicine in the COVID-19 era: Taking care of children with obesity and diabetes mellitus
por: Umano, Giuseppina Rosaria, et al.
Publicado: (2021)